Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1L8 Inhibitors

OR1L8 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the olfactory receptor 1L8 (OR1L8). Olfactory receptors, like OR1L8, are part of the G protein-coupled receptor (GPCR) family, primarily involved in detecting volatile compounds and enabling the sense of smell. These receptors play a key role in transducing chemical signals from odorants into neural signals through the binding of specific molecules. OR1L8, in particular, is one of the many olfactory receptors responsible for this molecular recognition process. Inhibition of OR1L8 can affect its ability to bind to specific ligands or alter the downstream signaling pathways. The inhibitors of OR1L8 act by either directly binding to the receptor site, preventing the interaction with its natural odorant ligands, or by interacting with associated signaling proteins that modulate its activity.

The structural diversity of OR1L8 inhibitors is notable, as these molecules must fit within the unique binding pocket of the OR1L8 receptor, which is shaped by the receptor's tertiary structure and amino acid composition. Typically, these inhibitors are small molecules that exhibit a high degree of specificity for OR1L8 over other olfactory receptors. This specificity is often achieved by designing or selecting compounds that exhibit favorable binding affinities to the receptor's active or allosteric sites. The understanding of OR1L8's three-dimensional structure and the dynamics of its binding site are crucial for the development of effective inhibitors. Additionally, OR1L8 inhibitors may influence not only ligand binding but also receptor dimerization, desensitization, or internalization processes, all of which are important aspects of GPCR function. Through studying these inhibitors, researchers can gain deeper insights into the receptor's role in olfactory signaling pathways and broader biochemical mechanisms.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

Calcium chelator that can prevent calcium-mediated signal transduction in olfactory neurons, thus indirectly inhibiting OR1L8 activity.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Blocks L-type calcium channels, likely affecting calcium influx and subsequent signaling in olfactory neurons, impacting OR1L8 function.

Lidocaine

137-58-6sc-204056
sc-204056A
50 mg
1 g
$50.00
$128.00
(0)

Sodium channel blocker that can inhibit action potential propagation in neurons, potentially reducing OR1L8-mediated signaling.

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

Inhibits CaM kinase II, an enzyme involved in the calcium signaling pathways, possibly affecting OR1L8-related signaling.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, which can increase cAMP levels, thereby potentially influencing the signaling cascade associated with OR1L8.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

Inhibits protein kinase A, which is involved in cAMP-dependent signaling pathways, potentially affecting OR1L8 function.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Inhibits G protein activation, which could alter G protein-coupled receptor signaling, relevant to olfactory receptors like OR1L8.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$27.00
$52.00
37
(1)

Blocks IP3 receptors and could disrupt intracellular calcium release, which is important for signal transduction in olfactory neurons, including OR1L8.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

Inhibits protein kinase C, an enzyme that plays a role in GPCR signaling, which can affect OR1L8 activity.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits myosin light chain kinase, which can affect cytoskeletal changes and cellular processes relevant to OR1L8 signaling.